Otsuka and GW extend cannabinoid collaboration
This article was originally published in Scrip
Executive Summary
GW Pharmaceuticals and Otsuka Pharmaceutical have extended their alliance for collaborative research into cannabinoid compounds for three years until the end of June 2013.